Kleo Pharmaceuticals, Inc.
Pharmaceutical company · New Haven, Connecticut, United States
Kleo Pharmaceuticals, Inc. is a pharmaceutical company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $21 million sold in a notice filed in 2019.
Kleo Pharmaceuticals at a glance
What does Kleo Pharmaceuticals do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $21.2 million sold (2019).
Frequently asked questions about Kleo Pharmaceuticals
Where is Kleo Pharmaceuticals headquartered?
Kleo Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut, United States.
What does Kleo Pharmaceuticals do?
Kleo Pharmaceuticals, Inc. is a pharmaceutical company.
When was Kleo Pharmaceuticals founded?
The earliest incorporation on record for Kleo Pharmaceuticals, Inc. is in 2015, according to public company registers.
Similar companies
- Arvinas, Inc.New Haven, Connecticut, United States
- Yarrow Bioscience, Inc.New Haven, Connecticut, United States
- Trevi Therapeutics, Inc.New Haven, Connecticut, United States
- Veradermics, IncNew Haven, Connecticut, United States
- Rallybio CorpNew Haven, Connecticut, United States
- Achillion Pharmaceuticals IncNew Haven, Connecticut, United States
- Biohaven Ltd.New Haven, Connecticut, United States
- BioXcel Therapeutics, Inc.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences